CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 142 filers reported holding CYTOMX THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.01 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $609,000 | +134.2% | 78,821 | +124.0% | 0.00% | – |
Q3 2019 | $260,000 | -50.3% | 35,182 | -24.5% | 0.00% | -100.0% |
Q2 2019 | $523,000 | +4.4% | 46,582 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $501,000 | -45.1% | 46,582 | -23.0% | 0.00% | -50.0% |
Q4 2018 | $913,000 | -23.9% | 60,482 | -6.8% | 0.00% | 0.0% |
Q3 2018 | $1,200,000 | +11.2% | 64,882 | +37.5% | 0.00% | 0.0% |
Q2 2018 | $1,079,000 | -12.8% | 47,200 | +8.5% | 0.00% | 0.0% |
Q1 2018 | $1,238,000 | – | 43,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG CAPITAL MANAGEMENT LLC | 6,450,000 | $8,320,500 | 1.17% |
BVF INC/IL | 6,595,801 | $8,508,583 | 0.23% |
Bronte Capital Management Pty Ltd. | 925,245 | $1,193,566 | 0.12% |
Formidable Asset Management, LLC | 318,111 | $410,363 | 0.09% |
Congress Park Capital LLC | 112,450 | $145,061 | 0.08% |
Forefront Analytics, LLC | 49,421 | $63,754 | 0.04% |
Ground Swell Capital, LLC | 10,966 | $14,146 | 0.02% |
Clearline Capital LP | 196,583 | $253,592 | 0.02% |
CORNERCAP INVESTMENT COUNSEL INC | 81,352 | $104,944 | 0.02% |
ACADIAN ASSET MANAGEMENT LLC | 2,646,190 | $3,412 | 0.01% |